Hepatic FDG uptake is associated with future cardiovascular events in asymptomatic individuals with non-alcoholic fatty liver disease (Q38421038)

2 September 2017

Hepatic FDG uptake is associated with future cardiovascular events in asymptomatic individuals with non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

2 September 2017

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

Seung Hwan Moon

1

1 reference

2 September 2017

Sun-Pyo Hong

2

1 reference

2 September 2017

Young Seok Cho

3

1 reference

2 September 2017

Tae Soo Noh

4

1 reference

2 September 2017

Joon Young Choi

5

1 reference

2 September 2017

Byung-Tae Kim

6

1 reference

2 September 2017

Kyung-Han Lee

7

1 reference

2 September 2017

28 October 2015

1 reference

Journal of Nuclear Cardiology

2 September 2017

1 reference

2 September 2017

24

1 reference

2 September 2017

3

1 reference

2 September 2017

892-899

1 reference

https://scigraph.springernature.com/pub.10.1007/s12350-015-0297-y

2 September 2017

0 references

cites work

High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Nonalcoholic fatty liver disease and the coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Fatty liver: a novel component of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Non-alcoholic fatty liver disease: the mist gradually clears

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Obesity, Inflammation, and Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Causes and metabolic consequences of Fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Hepatic steatosis is associated with increased hepatic FDG uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Imaging-based quantification of hepatic fat: methods and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12350-015-0297-Y

Non-alcoholic fatty liver disease and cardiovascular risk

21 January 2018

1 reference

12 December 2020

Screening for cancer with PET and PET/CT: potential and limitations.

1 reference

12 December 2020

Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C

1 reference

12 December 2020

Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.

1 reference

12 December 2020

NASH predicts plasma inflammatory biomarkers independently of visceral fat in men

1 reference

12 December 2020

Ultrasound scanning in the detection of hepatic fibrosis and steatosis

1 reference

12 December 2020

Accumulation of (18)F-FDG in the liver in hepatic steatosis

1 reference

12 December 2020

10.1007/S12350-015-0297-Y

Identifiers

DOI

1 reference

2 September 2017

1 reference